Incidental focal 18F-FDG uptake in the pituitary gland: Clinical significance and differential diagnostic criteria

Journal of Nuclear Medicine

Volumn 52, Issue 4, 2011, Pages 547-550

  Hyun, Seung Hyup ^a   Choi, Joon Young ^a   Lee, Kyun Han ^a   Choe, Yearn Seong ^a   Kim, Byun Tae ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

18FFD.G.; Focal uptake; Incidentaloma; PET CT; Pituitary gland

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DRUG ACCUMULATION; DRUG UPTAKE; FEMALE; HUMAN; HYPOPHYSIS; HYPOPHYSIS ADENOMA; INCIDENTAL FINDING; INCIDENTALOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROADENOMA; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING; BRAIN; HYPOPHYSIS TUMOR; METABOLISM; MIDDLE AGED; SCINTISCANNING; WHOLE BODY COUNTING;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PITUITARY GLAND; PITUITARY NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; ROC CURVE; TOMOGRAPHY, EMISSION-COMPUTED; WHOLE-BODY COUNTING;

EID: 79954578981     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.083733     Document Type: Article

References (19)

1. Chidiac RM, Aron DC. Incidentalomas: A disease of modern technology. Endocrinol Metab Clin North Am. 1997;26:233-253.
2. Molitch ME. Pituitary incidentalomas. Endocrinol Metab Clin North Am. 1997;26:725-740. (Pubitemid 27528195)
3. Molitch ME. Pituitary tumours: Pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab. 2009;23:667-675.
4. Koo CW, Bhargava P, Rajagopalan V, Ghesani M, Sims-Childs H, Kagetsu NJ. Incidental detection of clinically occult pituitary adenoma on whole-body FDG PET imaging. Clin Nucl Med. 2006;31:42-43. (Pubitemid 43011939)
5. 18FFDG PET/CT: A multicentre study. Eur J Nucl Med Mol Imaging. 2010;37:2334-2343.
6. Campeau RJ, David O, Dowling AM. Pituitary adenoma detected on FDG positron emission tomography in a patient with mucosa-associated lymphoid tissue lymphoma. Clin Nucl Med. 2003;28:296-298. (Pubitemid 38281947)
7. Komori T, Martin WH, Graber AL, Delbeke D. Serendipitous detection of Cushing's disease by FDG positron emission tomography and a review of the literature. Clin Nucl Med. 2002;27:176-178. (Pubitemid 34195228)
8. 18F-FDG PET/CT: Clinical significance and improved characterization. J Nucl Med. 2006;47:609-615.
9. 18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer. AJNR. 2009;30:1431-1434.
10. 18F-FDG uptake: Incidence, localization patterns, and clinical significance. J Nucl Med. 2005;46:758-762.
11. 18FFDG uptake in the breast detected by PET/CT: Incidence and clinical significance. Eur J Nucl Med Mol Imaging. 2009;36:1558-1564.
12. Ezzat S, Asa SL, Couldwell WT, et al. The prevalence of pituitary adenomas: A systematic review. Cancer. 2004;101:613-619. (Pubitemid 38970613)
13. Nammour GM, Ybarra J, Naheedy MH, Romeo JH, Aron DC. Incidental pituitary macroadenoma: A population-based study. Am J Med Sci. 1997;314:287-291. (Pubitemid 27481524)
14. Yue NC, Longstreth WT Jr, Elster AD, Jungreis CA, O'Leary DH, Poirier VC. Clinically serious abnormalities found incidentally at MR imaging of the brain: Data from the Cardiovascular Health Study. Radiology. 1997;202:41-46. (Pubitemid 27024106)
15. 18F-FDG PET/CT. Nucl Med Mol Imaging. 2008;42:456-463.
16. Cho SK, Choi JY, Lee JY, et al. Clinical significance of incidental focal FDG uptake on prostate glands [abstract]. J Nucl Med. 2009;50(suppl 2):1814.
17. Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: A simulation study. J Nucl Med. 2004;45:1519-1527. (Pubitemid 47618506)
18. Keyes JW Jr. SUV: Standard uptake or silly useless value? J Nucl Med.1995;36:1836-1839.
19. Westerterp M, Pruim J, Oyen W, et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: Effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging.2007;34:392-404. (Pubitemid 46295349)